Clinical Trials Update: April 25, 2005
Multiple Myelomas Malignant Melanoma Diabetic Neuropathy
(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
This study will evaluate the spleen during PBPC mobilization by filgrastim. Volunteers 18 years or older with no history of splenectomy, and no previous PBPC mobilization attempts may be eligible. Research sites located in Massachusetts, Missouri and Wisconsin.
This study will evaluate the anticancer agent STA-4783, a taxane potentiator, which enhances the antitumor response of paclitaxel. Research sites located throughout the United States.
This research study will assess the safety and effectiveness of an investigational drug compared with placebo in reducing pain in patients with painful diabetic neuropathy. Research sites located in Texas, Nebraska and Massachusetts.
Copyright 2005 CenterWatch. All rights reserved.